What Happened
Nuvama Research forecasts Reliance Industries (RELIANCE) to report a significant 17% year-on-year growth in Q2FY27 EBITDA, reaching Rs 53,700 crore. This growth is primarily attributed to improved refining margins and higher throughput in its Oil-to-Chemicals (O2C) business, indicating a strong operational performance for the quarter.
Why It Matters (for you)
This projection is crucial for the Indian market as RELIANCE is a heavyweight on both Nifty and Sensex. A strong earnings report from such a large-cap company can significantly influence overall market sentiment, potentially leading to an upward revision in broader market indices and attracting FII interest, especially during the ongoing earnings season.
Impact on Indian Markets
The primary beneficiary is RELIANCE, which could see positive price action on the back of these strong growth projections. The positive outlook for the O2C segment might also indirectly benefit other refining and petrochemical players, though RELIANCE's scale makes its impact unique. The long-term New Energy outlook could also draw attention to the broader renewable energy sector.
What Traders Should Watch Next
Traders should closely monitor the actual Q2FY27 results announcement from Reliance Industries for confirmation of these projections. Key metrics to watch include O2C segment performance, refining margins, and any updates on the New Energy business. Any deviation from Nuvama's estimates could lead to volatility, so watch for post-earnings analyst commentary and price action.
Key Evidence
- Reliance Industries expected to report 17% YoY growth in Q2FY27 EBITDA to Rs 53,700 crore.
- Growth is led by stronger refining margins and higher throughput in the O2C business.
- New Energy business projected to reach Rs 20,100 crore EBITDA by FY30.
- Nuvama Research retains a Buy rating on RELIANCE with a target price of Rs 1,766.
- Risk flag: Unexpected decline in global crude oil prices impacting refining margins.